Arno van der Ark is working for more than 35 years in vaccine development, ranging from developing alternatives to animal testing, removing of animal derived raw materials in vaccine production processes, developing a safe and effective intranasal pertussis OMV vaccine and lately managing the further developing vaccine concepts to a first in human study for multiple clients.